NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

vator,

One way to be in this stock is to put the history of this company’s achievements together on a time line and ignore the stock price except for when obviously great opportunities to buy come along at or near the lowest level uptrend. The $350,000,000 PIM funding will suffice for about 2,000 patients if all the funding is used for GBM patients which is not likely though close to being possible because of need and demand. Current capacity at Sawston is about 100 patients per month and the UK GBM rate is over 200 patients per month plus rGBM patients. Then there will be self pay cases from around the world to consider. Memphis has a license to produce for Europe. Memphis has been adding lots of positions since earlier this year. Canada has a reciprocal agreement with the UK. Mr. Powers is from Canada. Kristyn Powers, his daughter, is liaison in Canada for NWBO as their employee. Seeing what is happening before others realize it is a very distinct advantage IF you have the time to wait for what is coming. By the way, cash positions are being gobbled up by inflation so there is that to consider too. Best wishes.